medline.ch Onkologie Urologische Tumoren

conid:1879
-kaloNeDinamik-------------------------------------------jo
-session-------------------------------------------Array
(
    [ID_S] => IP: 3.236.248.157; DATE: 2023/02/08/ 18:59:43
    [tip] => 2
    [contentType] => db
    [ses_userid] => 2
    [thisMode] => 
    [level_0] => 2
    [level_1] => 15
    [level_2] => 3
    [level_3] => 0
    [level_4] => 0
    [level] => 2
    [nodetype] => 2
    [node_family_id] => 0
    [monitor] => content
    [id_contentit_from_php_file] => 1879
    [uniqueid] => 202302081859433236248157398
    [lang] => Lng1
    [contentId] => 1879
    [browser] => IE
    [clas_css] => 0
    [level_p] => 2
    [lng] => Lng1
    [nodetype_ci] => -1
    [usr] => 0
    [vazhdopunen] => po
    [search_for] => ("urogenital neoplasms"[Majr] OR (("neoplasm"[ti] OR neoplasms[ti] OR cancer[ti] OR carcinoma[ti] OR tumor[ti] OR tumour[ti] OR "secondary"[subheading:majr]) AND (bladder[ti] OR prostatic[ti] OR prostate[ti] OR testicular[ti] OR testis[ti] OR penile[ti] OR kidney[ti] OR renal[ti]))  AND ("practice guideline" OR systematic[sb] OR "clinical trials"[mesh] OR "meta analysis"[pt] OR "epidemiologic studies"[mesh] OR randomi* OR "meta analysis" OR "evidence based" OR placebo* OR "single blind" OR "double blind" OR "control group" OR "triple blind" OR study[ti] OR studies[ti] OR trial[ti] OR trials[ti] OR consensus OR placebo OR review[pt] OR "sensitivity and specificity"[MeSH Terms] OR diagnos*[Ti] OR diagnosis[MeSH:noexp] OR diagnostic *[MeSH:noexp] OR diagnosis,differential[MeSH:noexp] OR diagnosis[Subheading:noexp] OR accuracy[Title/Abstract] OR "predictive value"[Title/Abstract]) AND (english[language] OR german[language] OR french[language] OR italian[language] OR spanish[language]) NOT (veterinary[subheading] OR "genital neoplasms, female"[mesh])
)

medline.ch

En | De

Impressum | Feedback

Sie sind hier: Onkologie » Urologische Tumoren

08. Februar 2023

Kardiovaskuläre Erkrankungen

Muskuloskelettale Erkrankungen

Gynäkologische Tumoren

Schrift:

Seite 1 von 7568


	Artikel 1 - 20 / 151360

	Body composition parameters were associated with response to abiraterone acetate and prognosis in patients with metastatic castration-resistant prostate cancer. Cancer Med Ke ZB, You Q, Xue YT, Sun JB, Chen JY, Liu WQ, Wei Y, Zheng QS, Li XD, Xue XY, Xu N. PMID: 36750989 [PubMed - as supplied by publisher]
	Patients' Individualized Care Perceptions and Health Literacy Using an Interactive App During Breast and Prostate Cancer Treatment: Two Parallel Randomized Controlled Trials. Comput Inform Nurs Crafoord MT, Sundberg K, Nilsson MI, Fjell M, Langius-Eklöf A. PMID: 36749849 [PubMed - as supplied by publisher]
	The Evidence for Using Artificial Intelligence to Enhance Prostate Cancer MR Imaging. Curr Oncol Rep Canellas R, Kohli MD, Westphalen AC. PMID: 36749494 [PubMed - as supplied by publisher]
	Clinical significance of galectin-3 expression in urinary bladder carcinoma. J Int Med Res Al-Maghrabi JA, Khabaz MN. PMID: 36748414 [PubMed - indexed for MEDLINE]
	Renal angiomyolipoma with inferior vena cava and right atrial embolism: A case report and literature review. Zhong Nan Da Xue Xue Bao Yi Xue Ban Liu H, Xiao E. PMID: 36748389 [PubMed - indexed for MEDLINE]
	Deepfake Histologic Images for Enhancing Digital Pathology. Lab Invest Falahkheirkhah K, Tiwari S, Yeh K, Gupta S, Herrera-Hernandez L, McCarthy MR, Jimenez RE, Cheville JC, Bhargava R. PMID: 36748189 [PubMed - indexed for MEDLINE]
	Glutathione-S-Transferase p1 Gene Promoter Methylation in Cell-Free DNA as a Diagnostic and Prognostic Tool for Prostate Cancer: A Systematic Review and Meta-Analysis. Int J Endocrinol Ye J, Wu M, He L, Chen P, Liu H, Yang H. PMID: 36747996 [PubMed]
	Oncologic and perioperative outcomes of laparoscopic versus open radical nephrectomy for the treatment of renal tumor (> 7 cm): a systematic review and pooled analysis of comparative outcomes. World J Surg Oncol Wang L, Li KP, Yin S, Yang L, Zhu PY. PMID: 36747217 [PubMed - indexed for MEDLINE]
	Ferroptosis-associated lncRNA prognostic signature predicts prognosis and immune response in clear cell renal cell carcinoma. Sci Rep Lai J, Miao S, Ran L. PMID: 36747047 [PubMed - indexed for MEDLINE]
	Stereotactic body radiation therapy for kidney cancer. Where do we stand? Int J Urol Sosa-Fajardo P, Blanco-Suarez JM, Pineda-Munguía Á, Rubí-Olea L, Peleteiro-Higuero P, Gajate P, Zafra-Martín J, Siva S, Bossi A, López-Campos F, Couñago F. PMID: 36746747 [PubMed - as supplied by publisher]
	Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsy on the Risk of Upgrading in Final Pathology in Prostate Cancer Patients Undergoing Radical Prostatectomy? An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study. Eur Urol Focus Zattoni F, Marra G, Martini A, Kasivisvanathan V, Grummet J, Harkin T, Ploussard G, Olivier J, Chiu PK, Valerio M, Marquis A, Gontero P, Guo H, Zhuang J, Frydenberg M, Moon D, Morlacco A, Kretschmer A, Barletta F, Heidegger I, Tilki D, van den Bergh R, Dal Moro F, Briganti A, Montorsi F, Novara G, Gandaglia G, EAU-YAU Prostate Cancer Working Party. PMID: 36746729 [PubMed - as supplied by publisher]
	Efficacy and safety of nivolumab in bone metastases from renal cell carcinoma: Results of the GETUG-AFU26-NIVOREN multicentre phase II study. Eur J Cancer Velev M, Dalban C, Chevreau C, Gravis G, Negrier S, Laguerre B, Gross-Goupil M, Ladoire S, Borchiellini D, Geoffrois L, Joly F, Priou F, Barthelemy P, Laramas M, Narciso B, Thiery-Vuillemin A, Berdah JF, Ferrari V, Dominique Thomas Q, Mione C, Curcio H, Oudard S, Tantot F, Escudier B, Chabaud S, Albiges L, Thibault C. PMID: 36746010 [PubMed - as supplied by publisher]
	The ratio of adaptive to innate immune cells differs between genders and associates with improved prognosis and response to immunotherapy. PLoS One Ahrenfeldt J, Christensen DS, Østergaard AB, Kisistók J, Soka, Birkbak NJ. PMID: 36745657 [PubMed - indexed for MEDLINE]
	Enhancing public awareness and practice of prostate cancer screening among African men: A scoping review. S Afr Fam Pract (2004) Benedict MO, Steinberg WJ, Claassen FM, Mofolo N. PMID: 36744487 [PubMed - indexed for MEDLINE]
	The profile of Black South African men diagnosed with prostate cancer in the Free State, South Africa. S Afr Fam Pract (2004) Benedict MOA, Steinberg WJ, Claassen FM, Mofolo N. PMID: 36744484 [PubMed - indexed for MEDLINE]
	A Retrospective Study of the Effect of Metformin on Patients with Metastatic Prostate Cancer. Clin Med Insights Oncol Lee CS, Lam SY, Liu A, Sison C, Zhu XH. PMID: 36744171 [PubMed]
	Targeting lipid metabolism in metastatic prostate cancer. Ther Adv Med Oncol Scheinberg T, Mak B, Butler L, Selth L, Horvath LG. PMID: 36743527 [PubMed]
	Androgen receptor pathway inhibitors, prostate cancer, and older adults: a global Young International Society of Geriatric Oncology drug review. Ther Adv Med Oncol Mir N, Burke O, Yates S, Rajasekaran T, Chan J, Szmulewitz R, Kanesvaran R. PMID: 36743522 [PubMed]
	Patterns of treatment in older patients with newly diagnosed advanced bladder cancer: A SEER dataset analysis. Aging Cancer Kessler ER, Schmiege SJ, Eguchi M, Singh S, Fischer SM. PMID: 36742442 [PubMed]
	Prognostic value of estrogen receptors in patients who underwent prostatectomy for nonâ€‘metastatic prostate cancer. Oncol Lett Ayd, , Dölek R, Vuru, Ocako, Vuru, Yava, Co. PMID: 36742361 [PubMed]

Artikel 1 - 20 / 151360

Seite 1 von 7568

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung